Bank Of New York Mellon Corp Humacyte, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.11 - $3.25 $553,189 - $852,068	262,175 New	262,175 $810 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.62 $540,768 - $969,099	267,707 New	267,707 $564,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $5.14 $16,513 - $69,575	13,536 Added 24.07%	69,776 $227,000
Q2 2022 Aug 15, 2022	BUY	$3.21 - $7.86 $95,009 - $232,640	29,598 Added 111.1%	56,240 $180,000
Q1 2022 May 11, 2022	BUY	$4.65 - $7.4 $123,885 - $197,150	26,642 New	26,642 $188,000

172

41M

553K

942K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $365M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.